Advances in CAR ‐T therapy for small cell lung cancer
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70093 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Qiuyue Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Science, China Three Gorges University, Yichang, China. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Immunotherapy, Adoptive, Lung Neoplasms, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Hubei Provincial Natural Science Foundation of China, Yichang Science and Technology Project, Teaching Reform Research Project of Three Gorges University (J2024097).
Abstract (Originalsprache)
Small cell lung cancer (SCLC), a highly aggressive subtype of lung cancer, has limited treatment options and a poor prognosis for patients. Traditional treatments, including platinum‐based drugs and etoposide chemotherapy, provide good initial responses but are highly susceptible to drug resistance, resulting in a markedly reduced long‐term survival rate. In recent years, the success of chimeric antigen receptor T cell (CAR‐T) therapy in hematologic malignancies and its potential in the treatment of solid tumors have brought new hope for the treatment of SCLC. This article presents a review of the application of CAR‐T cell therapy in SCLC, including an examination of the structural optimization of CAR‐T cells, an analysis of therapeutic targets for SCLC, and a discussion of the latest progress in preclinical and clinical research. The objective of this study is to present novel insights and pioneering strategies for immunotherapy in SCLC, with the aim of advancing the field of tumor immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Science, China Three Gorges University, Yichang, China.
- Key Laboratory of Brain, Cognition and Education Sciences, Institute for Brain Research and Rehabilitation, Guangdong; Key Laboratory of Mental Health and Cognitive Science, Ministry of Education, South China Normal Uni…
ORCID-Profile: Xun Li
Förderung
- Hubei Provincial Natural Science Foundation of China
- Yichang Science and Technology Project
- Teaching Reform Research Project of Three Gorges University (J2024097)
Zitieren
APA
Zhang, Q., Fu, Q., Hou, Y., Lv, Y., Cao, C., & Li, X. (2026). Advances in CAR ‐T therapy for small cell lung cancer. International Journal of Cancer. https://doi.org/10.1002/ijc.70093
Vancouver
Zhang Q, Fu Q, Hou Y, Lv Y, Cao C, Li X. Advances in CAR ‐T therapy for small cell lung cancer. International Journal of Cancer. 2026. doi:10.1002/ijc.70093
BibTeX
@article{Zhang2026,
author = {Zhang, Qiuyue and Fu, Qi and Hou, Yanan and Lv, Yafeng and Cao, Chunyu and Li, Xun},
title = {Advances in CAR ‐T therapy for small cell lung cancer},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70093}
}
EUVIMED